Source: Annual Congress 2004 - Inflammation and smoking induced effects
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Fira-Mladinescu, D. M. Danila, D. M. Muntean, C. Fira-Mladinescu, S. Mihaicuta, V. Tudorache, A. Cristescu (Timisoara, Romania). Smoking induced endothelial dysfunction in isolated rabbit pulmonary arteries. Eur Respir J 2004; 24: Suppl. 48, 3421

Member's Comments

No comment yet.

Related content which might interest you: Primary pulmonary hypertension and endothelial dysfunction Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Peripheral endothelial dysfunction in patients with pulmonary artery hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 The protective role of a natural antioxidant on cigarette smoke induced endothelial dysfunction in rabbit pulmonary arteries Source: Eur Respir J 2005; 26: Suppl. 49, 153s Year: 2005 Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007 Cigarette smoke exposure induces endothelial dysfunction in pulmonary arteries in the guinea pig Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease" Year: 2006 Cell freehaemoglobin and pulmonary artery endothelial cell dysfunction Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Endothelial cell viability before and after revascularization of chronically obstructed pulmonary artery in pig Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension Year: 2004 Vascular reverse remodeling in the mouse model of hypoxia-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Hyperplasia of pulmonary artery smooth muscle cells in primary and secondary pulmonary hypertension is causally related to serotonin transporter overexpression Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 LSC - 2018 - Pulmonary vascular remodeling mediated by ADORA2B in pulmonary artery smooth muscle cells Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Alkalosis induce eNOS activation in human pulmonary arterial endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021